Policy & Medicine – Page 30 – Legal, Regulatory, and Compliance Issues

Vaccination at Risk: Tackling PBM Barriers to Ensure Equitable Access and Sustain Supply

Strengthening Mental Health Parity: New Rules Enhance Compliance and Network Adequacy Under MHPAEA

This Week on Policy and Medicine Podcast November 23, 2024: Legal Battles, Regulatory Updates, and Unveiling Silent Threats

2023 PCE Oncology Fall Conferences: An Essential Learning Opportunity for Oncology Healthcare Professionals

CMS Announces New Slate of Reduced Coinsurance Drugs for Q4 2023

The Importance of Intellectual Property Protections for Patients

Legislation Introduced to Enhance Value-Based Purchasing Arrangements in Medicaid

Telemedicine Leads to Fewer Follow-Up Visits When Compared to In-Person Visits

FDA Releases Draft Guidance on Unapproved Use Communications from Firms to Health Care Providers

HHS OIG Expands Enforcement Authority to Grant and Contract Fraud

2023 PCE Primary Care Fall Symposia: A Must-Attend Event for NPs and PAs

Policy and Medicine Compliance Update October 2023 Issue Features: Complex World of Medical Education, FDA Regulation of Laboratory Developed Tests, FDA Post Marketing Requirements, Distinct Roles of Legal and Compliance and Teva’s Generic Price Fixing Settlement

Indivior and Health Plans Reach $30 Million Class Action Settlement, Pending Approval